(Q40846872)

24 September 2017

Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119512

8 August 2023

author name string

B. J. Anders

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119512

8 August 2023

B. A. Lauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119512

8 August 2023

J. W. Paisley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119512

8 August 2023

L. B. Reller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119512

8 August 2023

language of work or name

English

0 references

publication date

1 January 1982

1 reference

24 September 2017

16 January 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6119512

full work available at URL

8 August 2023

https://api.elsevier.com/content/article/PII:S0140673682903804?httpAccept=text/xml

1 reference

10.1016/S0140-6736(82)90380-4

DOI

https://api.crossref.org/works/10.1016/S0140-6736(82)90380-4

https://api.elsevier.com/content/article/PII:S0140673682903804?httpAccept=text/plain

8 August 2023

1 reference

10.1016/S0140-6736(82)90380-4

DOI

https://api.crossref.org/works/10.1016/S0140-6736(82)90380-4

8 August 2023

1 reference

24 September 2017

1

1 reference

24 September 2017

8264

1 reference

24 September 2017

131-132

1 reference

24 September 2017

Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Related vibrio in stools

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Campylobacter enteritis: a "new" disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Campylobacter Enteritis: Clinical and Epidemiologic Features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Campylobacter enteritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Absorption of Erythromycin from Pediatric Suspension in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

Campylobacter gastroenteritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2990380-4

7 January 2021

10.1016/S0140-6736(82)90380-4

Identifiers

DOI

1 reference

24 September 2017

1 reference